chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tiredness; mouth sores; it looked red and swollen and it hurt; patient cannot really eat; gum inside cheek have white spots on it; it looked red and swollen and it hurt; it looked red and swollen and it hurt; It was more of the cheek inside the mouth, that's painful; It was not open sore but it was just red; Tenderness of lymph nodes/Lymph node is kind of tender; swelling of the lymph node; This is a spontaneous report from a contactable nurse (patient). A 59-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot #: not sure EL3249 or EU3249), via an unspecified route of administration on 11Jan2021 at single dose at left deltoid for covid-19 immunization. Medical history included hypertension, hypothyroidism, heartburn. Concomitant medications included levothyroxine for hypothyroidism, olmesartan, hydrochlorothiazide, amlodipine, omeprazole for heartburn, alprazolam. Patient had the tiredness, mouth sores or something like that in Jan2021. When patient look at her cheek, the gum inside cheek have white spots on it and it looked red and swollen and it hurt, especially the left side and that bothered patient because patient cannot really eat and it hurt. It was more of the cheek inside the mouth, that's painful. It's not open sore but it's just red and like tender. And also patient had a tenderness of lymph nodes on the left neck. For causality, the patient thought so because nothing has changed since before patient got the vaccine. Patient didn't have any of this, especially the sore in the mouth. Patient cannot eat on the left side because it hurt. But the rest of the symptoms which was the tiredness and the swelling of the lymph node, lymph node was kind of tender but it's only on the left side, that's listed as the side effects. But the sores in the mouth was not listed that's why patient was worried about that. Lab work: results were okay. The tiredness, it was like patient got it in the morning, so patient slept. Patient went straight after work, then patient slept. When patient started getting ready for work and the alarm went off, patient was extra tired so I called out sick, but patient was okay. For treatment, patient took naproxen sodium (ALEVE) and then, because patient was at work and yesterday it was really bothering patient because it was hurting. It started hurting really more when the evening was on. Then patient took paracetamol (TYLENOL), then the nystatin solution, patient tried to swish and it helped a little bit with the pain. Due date for the next dose was 08Feb2021. Outcome of events was unknown.   Information on the lot/ batch number has been requested.
After the second dose, rash developed on upper left arm where vaccine was given, rash started a day or two after the shot and lasted about a week before it started going away.; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 02Apr2021 at 12:45 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included acetylsalicylic acid (ASPIRIN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 12Mar2021 at 12:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021, after the second dose, the patient developed rash on upper left arm where vaccine was given, rash started a day or two after the shot and lasted about a week before it started going away. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on upper left arm where vaccine was given was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Tuesday evening / fever of 104, 5pm Dizzyness, chills, aches, nausea, vomiting Treated with tylenol fever dropped to 102 Vomited at midnight Fever controlled with Tylenol fever stayed at 100  Wednesday woke with fever 101, aches chills, headache  Controlled with Tylenol Noon fever was below 100  Realized loss of sense of taste  Thursday morning fever was back with 101 Controlled with Tylenol  Fever went down blow 100  Stayed tired still no sense of taste
strip of redness from injection site which extendes to about 2.5 inches with  itching; strip of redness from injection site which extendes to about 2.5 inches; arm pain/ pain; soreness to the touch / tenderness / pain; loss of appetite; low energy; foggy; low grade fever of 99.8; dizziness; headache; chills; feeling more cold than normal; This case was reported by a consumer via call center representative and described the occurrence of injection site itching in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included breast cancer. Concurrent medical conditions included hot flashes.   On 16th October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 weeks after receiving Shingrix, the patient experienced injection site itching, injection site erythema, pain in arm, tenderness, appetite lost, energy decreased, foggy feeling in head, fever, dizziness, headache, chills and feeling cold. On an unknown date, the outcome of the injection site itching, appetite lost, energy decreased, foggy feeling in head, dizziness, headache, chills and feeling cold were unknown and the outcome of the injection site erythema, pain in arm, tenderness and fever were not recovered/not resolved.   It was unknown if the reporter considered the injection site itching, injection site erythema, pain in arm, tenderness, appetite lost, energy decreased, foggy feeling in head, fever, dizziness, headache, chills and feeling cold to be related to Shingrix.  Additional details were provided as follows: The patient was a breast cancer survivor. The patient received the first dose of the Shingrix vaccine in her right arm. The patient reported right arm pain and soreness to touch and there was a strip of redness from injection site which extended to about 2.5 inches with  itching. The patient experienced headache, chills, feeling more cold than normal, low grade fever of 99.8 degree F, low energy, loss of appetite, dizziness, and foggy.  Most of the adverse event had resolved. The reporter at the time of reporting still had low grade fever, redness of the injection site of the right arm, tenderness and pain. The reporter consented to follow up.
pt rec'd grey cap pfizer vaccine after it was stored in freezer for 22 days- patient is aware and will be in at some point for replacement dose
1) 5 min after injection, heat flush & abd cramping. 2) 10 min after, itching & heat @ injection site. 3) 15 min after, itching & hives over entire arm/shoulder area. 50mg Benadryl given. 4) 25-30 min after, heat flush, diaphoretic taken next door to urgent care. 5) 45 min after, diaphoretic, shortness of breath, spasms in throat. Epi dose of 0.3mg given. Ambulance called to urgent care. 6) ER - O2 100% NRB face mask, patient doesn't remember other treatments except stated she was given ativan.  She was in the hospital for 3 days.  After discharge, saw primary care physician for severe arm pain & swelling.  Ultrasound showed DVT in arm from infiltrated IV. Currently on Coumadin for 6 months.  Primary physician will have to strip vein. Released for return to work on 10/31/08.  2/10/2009 MR received for DOS 10/10-12/2008 with D/C DX:  Anaphylactic Reaction to Flu vaccine.  Mild metabolic acidosis.  Tachycardia. Pt presented to ER following receipt of Flu shot and immediate flushing, hives, diaphoresis, abdominal pain and H/A. Received Benadryl, Solumedrol and epi prior to arrival with poor response. Becam tachycardic, hypertensive and anxious en route to hospital. Upon arrival pt still c/o of throat closing and difficulty breathing. BP 212/69. PE WNL. Admitted for further med mgmt.
Diagnosed with Ramsay Hunt Syndrome.    5 days after booster - noted inflammation and pain on tongue. 8 days after booster - experienced pain in ear/jaw. 9 days after booster - sought urgent medical care for facial paralysis on right side. Bell's palsy triggered by shingles suspected. 12 days after booster - Neurologist confirms Ramsay Hunt Syndrome.
On 11/8/2023 resident developed bruising and the anterior right shin.  This progressed to increased pain and swelling of the area.  11/9/2023 pain and swelling continued. Call placed to Hospice to notify of ongoing pain and swelling.  Pain medications increased and monitoring continued.  Hospice nurse visited resident in the afternoon of 11/9, picture taken by hospice nurse and sent to provider.  Order received to obtain x-ray of RLE to r/o trauma.  11/10/2023: Morning - continues to have swelling and pain in RLE - also now noted with increasing warmth and erythema.  Order for X-ray cancelled d/t progressing course of illness. No ultrasound ordered d/t goals of care. Diagnosis of DVT based on clinical presentation. All scheduled (non-comfort) medications discontinued.
Patient reportedly recevied COVID vaccine on 2/25/21 but unsure of manufacterer or lot number.  Patient admitted to hospital on 3/17 for altered mental status and suspected UTI.  COVID screen test on 3/17 resulted positive.  Patient was asymptomatic for COVID.  Patient was discharged on 3/21/21 with no clinical deterioration from COVID.
This patient received his 1st dose of Moderna with another facility on 4/13/2021. This patient came into reporting facility stating he needed his 2nd dose. The administering nurse did not verify the date of the 1st dose prior to administering the 2nd dose. This patient was due for his second dose on 5/11/2021 as his 1st dose was 4/13/2021. No adverse event noted after administration.
Pt recvd vax 23OCT92 & 25OCT92 & 36 hrs following vax pt devel large white nonpruritic painful irregular skin eruptions on knees & ankles which progressed to back & stomach & eventually covered entire body; c/o pain & swelling; also virus;
Petechia. Mom reports she noticed a dotted like rash on ride home from office. Called office advised to come back. Doctor examined, diagnosed, order lab work. Rash was gone in 2 days.
severe hives (rash rx pred started w/just a few red spots 1 day p/vax;severe hives bright-red all over 2 days p/shot & took to MD;
My body started to tingle and my throat started getting tight. It lasted for about 40 minutes.
Areas of mouth irritation about 10 days after first shot. Mouth sores 4 days after second shot. Still have new areas of mouth irritation One month after initial 1st dose.
7 x 7 cm area of redness, heat, swelling, with increased swelling in center. 2 x 1.5 cm ecchymotic area. C/O pain, pruritus.
hives; it itches too much that it prevents her from sleeping; it itches too much that it prevents her from sleeping; This is a spontaneous report from a contactable nurse. A 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Right arm on 19Jan2021 16:00 (Batch/Lot Number: EL3249) as dose 2, single for COVID-19 immunisation. The patient medical history included blood pressure and cholesterol. Concomitant medications included gliclazide (DIAZIDE) for blood pressure from 2014; vitamin D and calcium taking over 5 years, for bones; linum usitatissimum oil (FLAXSEED OIL) taking over for heart, cholesterol; biotin taking over 5 years for hair and skin. Patient had no history of previous immunisations and did not receive any other vaccines within four weeks. No family history reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number : EK9231, via an unspecified route of administration in right arm, on 29Dec2021 16:00, as single dose for COVID-19 immunization. On 20Jan2021, she first noticed hives on the left hand and she thought they were bites on her knuckles. But then the hives appeared on her back and then it went to her chin, face, arms, legs, toes. The patient added they were most noticeable at night; and they were very itchy hives. At first they thought it might be related to the mask she has to wear, but now she didn't think the hives related because even when she is home for five days with no masks or gloves or any exposure to the chemicals at work, she still had the hives. The patient added the second dose of the vaccine is the dose she is concerned about. She didn't have anything after the first dose. The patient added she started taking Zyrtec and then added Pepcid because it is a H1 blocker and still continued to have hives. At night she took Benadryl and sometimes famotidine, too. After two weeks, she tried two Medrol dose packs and they did nothing. The patient added nothing has changed in her routine at home of showering or of soaps, creams, shampoos since before the vaccination. She believes the second dose of the vaccine caused the hives. The patient added she thinks it is an immune response maybe to a preservative in the vaccine. The patient added at the night on 18Mar2021 about 12:30, she didn't take any medication and woke up with such intense itching that she had to take a Benadryl. It itched too much that it prevented her from sleeping. The patient mentioned she worked in surgery three 12 hour shifts and then two 8s and has not had time to go to a doctor. The patient added she did show the hives to the surgeons she works with. The patient added she was not allergic to anything.  She has an appointment with dermatologist on 27Apr2021. No relevant test was done. The outcome of the event insomnia was unknown and of other events was not recovered.  No follow-up attempts are needed. No further information is expected.
low grade fever; soreness in my left arm; On 10/25 and 10/26 I experience tenderness under my left armpit.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 23Oct2021 16:00 (Lot number: 320308D) at the age of 42 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU, administration date 09Oct2021; LEXAPRO. Past drug history included: No. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6205, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 15Apr2021, when the patient was 41 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9267, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 25Mar2021, when the patient was 41 years old, for COVID-19 Immunization. The following information was reported: PYREXIA (non-serious) with onset 25Oct2021, outcome "not recovered", described as "low grade fever"; PAIN IN EXTREMITY (non-serious) with onset 25Oct2021, outcome "not recovered", described as "soreness in my left arm"; TENDERNESS (non-serious) with onset 25Oct2021, outcome "not recovered", described as "On 10/25 and 10/26 I experience tenderness under my left armpit.". Therapeutic measures were not taken as a result of pyrexia, pain in extremity, tenderness.Prior to vaccination, the patient was not diagnosed with covid-19 and since the vaccination, patient was not diagnosed with covid-19.  No follow-up attempts are possible. No further information is expected. Device Date : 26Oct2021.
8/20/04: left leg swollen and red: whole upper thigh : necessary use of Ibuprofen q6 hours and warm moist compress and call private doctor. He recommended child be seen. Child taken to clinic and diagnosed with cellulitis left upper leg and given Keflex 250 x 7 days. Leg fine now. 8/25/04
23OCT95 pt woke up & noticed had red swollen area @ site of inj of Td;stated area felt feverish & was painful;redness ran all the way down half of lt arm;MD dx'd allerg rxn
MCV4 required liquid/powder (dual) vaccination. Only liquid was given incomplete vaccination. Needs to go revaccinate 8wks from 2/20/15.
Fever greater than 100 degrees F, full body muscle aches, chills, sore throat, tender armpit (left)- 12/27/2020 (all day) Itchy, blanched, swollen, hard, warm patch on left arm 4.5" x 3" with surrounding redness and tender armpit- 01/02/2021- present
I had very bad nausea, chill, and fever about 24 hours after my vaccine. The vaccine side effects were shorter but much more severe than my COVID-19 infection. On 6/18/2022, I went to a 300-guest wedding, and I think that is where I contracted COVID-19. On 6/19/2022 I started having body aches, fever, and general malaise on that evening. On 6/20/2022 I tested positive on a COVID-19 home test. I had a telehealth call with my doctor, and he prescribed PAXLOVID, and I started taking it that afternoon. I started taking PAXLOVID on Monday afternoon and by Thursday I felt a little bit okay, and I took another day off from work. By Friday, I felt fine. I did have the horrible metal taste while I was on PAXLOVID, that kind of killed my appetite.
A report has been received from a pharmacist concerning a subject of unknown gender, who had been receiving nasal FLUMIST started on an unknown date. The patient experienced received partial dose. The outcome of the event of received partial dose is unknown. The report was considered to be non-serious.
received expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received expired vaccine) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021 at 3:49 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 17-Dec-2021 at 3:49 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (received expired vaccine). On 17-Dec-2021 at 3:49 AM, EXPIRED PRODUCT ADMINISTERED (received expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided.   Most recent FOLLOW-UP information incorporated above includes: On 17-Dec-2021: Non-significant Follow up E-mail ID confirmed
Pain in my toes. Thigh pain. Lower back pain. Hip & groin pain. Diagnosed with spinal stenosis & perhaps arthritis. My condition is improving with medication, but I still have not fully recovered.
Father calls to report that patient has been feverish since yesterday evening; he has sore, swollen upper arms, feels lethargic and is not hungry.  Encouraged fluids, acetaminophen or ibuprofen and observation of patients condition.
Allergic reaction/she is having a reaction to vaccine; This is a spontaneous report from a contactable consumer or other non hcp.  A 26-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot Number: EN6206) as UNKNOWN, SINGLE DOSE for covid-19 immunisation  .  The patient medical history was not reported.  The patient's concomitant medications were not reported. The patient experienced allergic reaction/she is having a reaction to vaccine on an unspecified date. she had allergies to it she believed. She wanted to let them know symptoms and ask if there was anything to do for them. Caller does not clarify this statement other than to say she was doing many things at one time. Caller says she was panicking because she was having a reaction to vaccine and wants to ask what should she do. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
PT REPORTS EXPERIENCING INJECTION SITE PAIN INITIALLY, THEN STARTED TO FEEL WEAKNESS ABOUT 30 SECONDS AFTER THE SHOT (LEFT ARM). PER PT, THE WEAKENSS STARTED TO RADIATE THROUGH HER ENTIRE LEFT ARM 2 MINUTES AFTER THE VACCINE ADMINISTRATION. THEN THE WEAKNESS AND SWELLING SENSTATION TRAVELLED UP TO THE JAW (ONLY ON THE LEFT SIDE OF THE FACE). PT STATED THAT LEFT SIDE OF FACE FEEL SWOLLEN. SHE DESCRIBED IT AS "TOOTHACHE" AND FEELS LIKE LOCAL ANESTHETIC INJECTION FROM THE DENTIST. PER PT, PT FELT THE WEAKNESS BEFORE WITH GARDASIL BEFORE. HOWEVER, SWELLING SENSATION ON THE LEFT PART OF THE FACE IS NEW REACTION THAT SHE NEVER FACED BEFORE WITH ANY TYPE OF VACCINE. OBSERVED PT FOR FULL 30 MINUTES AND PT REPORTED IMPROVEMENT ON HER LEFT ARM AND LEFT SIDE OF HER FACE. PER PT, SHE DOES NOT HAVE A PCP. THEREFORE SUGGESTED HER TO REACH OUT TO EMERGENCY ROOM OR URGENT CARE, IF THESE SYMPTOMS WORSENS OR DOES NOT GET ANY BETTER WITHIN 24 HOURS.
dry heaves; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team. The reporter is the patient.  A 86 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. Relevant medical history included: "Had fell" (unspecified if ongoing), notes: was home bound. The patient's concomitant medications were not reported. The following information was reported: RETCHING (non-serious), outcome "unknown", described as "dry heaves".  Additional information: She got her first shot and another on the 14th of April. One day, she woke up and had dry heaves after her first shot but that was weeks later. It took her a long time to get this shot. She had fell and was home bound. Patient was querying if she was going to be ok with that one shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Itchy; hives on neck and chest; shortness of breath; chest pain; eyes puffed out really bad; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchy), URTICARIA (hives on neck and chest), PERIORBITAL SWELLING (eyes puffed out really bad), DYSPNOEA (shortness of breath) and CHEST PAIN (chest pain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Drug allergy (the patient was allergic to sulfa). Concomitant products included ESCITALOPRAM and ARIPIPRAZOLE for an unknown indication.    On 21-Jan-2021 at 10:12 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PERIORBITAL SWELLING (eyes puffed out really bad). On an unknown date, the patient experienced PRURITUS (Itchy), URTICARIA (hives on neck and chest), DYSPNOEA (shortness of breath) and CHEST PAIN (chest pain). The patient was treated with PREDNISONE ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PRURITUS (Itchy), URTICARIA (hives on neck and chest), PERIORBITAL SWELLING (eyes puffed out really bad), DYSPNOEA (shortness of breath) and CHEST PAIN (chest pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.